UPDATED Aug 27, 2025
Discover Global Pharmaceuticals & Biotech Growth Stocks from around the world. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
ALZN | US$2.46 | 4.7% | -88.1% | US$7.7m | US$45.00 | PB1.9x | E40.7% | n/a | ||
TNXP | US$32.18 | -10.7% | 7.2% | US$298.1m | US$61.67 | PS28.7x | E40.6% | n/a | ||
603590 | CN¥51.06 | -4.7% | 125.4% | CN¥7.9b | CN¥44.00 | PE180.4x | E40.1% | 1.2% | ||
ATOS | US$0.76 | 3.1% | -44.8% | US$100.1m | US$5.63 | PB1.7x | E40.1% | n/a | ||
ALLR | US$1.59 | 83.0% | -66.0% | US$18.3m | US$9.00 | PB1.7x | E39.8% | n/a | ||
GNS | UK£26.40 | -0.9% | 47.0% | UK£1.7b | UK£26.78 | PS2.6x | E39.8% | 1.2% | ||
LRMR | US$3.90 | 3.4% | -51.1% | US$331.2m | US$19.30 | PB2.8x | E39.5% | n/a | ||
TGTX | US$28.57 | 0.9% | 22.4% | US$4.1b | US$40.50 | PE68.9x | E39.3% | n/a | ||
7774 | JP¥485.00 | -5.8% | -17.4% | JP¥19.8b | JP¥1,200.00 | PS8.1x | E39.3% | n/a | ||
KURA | US$7.86 | 11.5% | -61.0% | US$657.9m | US$27.00 | PS8.2x | E39.1% | n/a | ||
300558 | CN¥68.78 | 7.3% | 96.3% | CN¥28.4b | CN¥63.16 | PE90.9x | E38.7% | 0.3% | ||
PYPD | US$3.42 | -2.3% | -2.3% | US$53.5m | US$12.50 | PB2.6x | E38.5% | n/a | ||
1801 | HK$91.00 | -3.9% | 106.3% | HK$155.9b | HK$88.27 | PS15.2x | E38.4% | n/a | ||
IMVT | US$15.18 | 2.4% | -51.6% | US$2.6b | US$39.46 | PB4.3x | E38.1% | n/a | ||
300702 | CN¥26.55 | -4.2% | 82.0% | CN¥9.3b | n/a | PE60x | E38.1% | 0.2% | ||
603538 | CN¥26.04 | -4.0% | 130.6% | CN¥6.2b | n/a | PE77.4x | E38.0% | 0.2% | ||
ROIV | US$11.99 | 2.3% | -0.08% | US$8.1b | US$17.11 | PS352.4x | E37.7% | n/a | ||
RNA | US$47.82 | 7.8% | 9.6% | US$6.1b | US$67.00 | PS573.4x | E37.7% | n/a | ||
SIGA | US$8.25 | -6.0% | -10.4% | US$607.9m | n/a | PE7.2x | E37.7% | 7.3% | ||
PLTH | CA$0.40 | 2.6% | -48.7% | CA$131.8m | n/a | PB1x | E37.5% | n/a | ||
CYBN | US$7.67 | 10.8% | -21.2% | US$181.0m | US$84.25 | PB1.2x | E37.4% | n/a | ||
MRNA | US$25.10 | -4.3% | -67.7% | US$9.8b | US$45.45 | PS3.2x | E37.3% | n/a | ||
INAB | US$2.28 | 1.8% | -85.4% | US$10.4m | US$58.10 | PB0.7x | E37.2% | n/a | ||
CUE | US$0.83 | 2.1% | 17.9% | US$64.6m | US$4.00 | PS7.7x | E37.2% | n/a |